Form 4: Disc Medicine Director Sells Shares
Insider Transaction (Form 4)
Kevin Bitterman, a Director of Disc Medicine, Inc., sold 27,136 shares of common stock on September 11, 2026 for $70.11 per share.
Summary
- Option exercise/conversion: acquired 7,136 Common Stock at $45.69 ($326,044) on September 11, 2026; holds 7,136 after (Direct).
- Option exercise/conversion: acquired 10,000 Common Stock at $38.85 ($388,500) on September 11, 2026; holds 17,136 after (Direct).
- Option exercise/conversion: acquired 10,000 Common Stock at $50.86 ($508,600) on September 11, 2026; holds 27,136 after (Direct).
- Open-market sale: disposed of 27,136 Common Stock at $70.11 ($1,902,505) on September 11, 2026 (Direct).
- Option exercise/conversion: disposed of 7,136 Stock Option (Right to Buy) on September 11, 2026 (Direct).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on September 11, 2026 (Direct).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on September 11, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,902,505 of stock on the open market.
Insider Transactions
Kevin Bitterman — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Option exercise/conversion | Common Stock | 7,136 | $46 | $326.0K | 7,136 |
| 2026-09-11 | Option exercise/conversion | Common Stock | 10,000 | $39 | $388.5K | 17,136 |
| 2026-09-11 | Option exercise/conversion | Common Stock | 10,000 | $51 | $508.6K | 27,136 |
| 2026-09-11 | Open-market sale | Common Stock | 27,136 | $70 | $1.9M | 0 |
| 2026-09-11 | Option exercise/conversion | Stock Option (Right to Buy) | 7,136 | — | — | 0 |
| 2026-09-11 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 0 |
| 2026-09-11 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Option exercise/conversion (7,136 shares) |
| 2026-09-11 | Option exercise/conversion (10,000 shares) |
| 2026-09-11 | Option exercise/conversion (10,000 shares) |
| 2026-09-11 | Open-market sale (27,136 shares) |
| 2026-09-11 | Option exercise/conversion (7,136 shares) |
| 2026-09-11 | Option exercise/conversion (10,000 shares) |
| 2026-09-11 | Option exercise/conversion (10,000 shares) |
Keywords
insider transaction, Form 4, IRON, Disc Medicine, Inc., bearish, Kevin Bitterman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.